(Q38984496)

8 September 2017

title

Effect of HIF1α on Foxp3 expression in CD4+ CD25- T lymphocytes (English)

1 reference

8 September 2017

Jianguo Wu

1

1 reference

8 September 2017

Hongyan Cui

2

1 reference

8 September 2017

Zhifeng Zhu

3

1 reference

8 September 2017

Li Wang

4

1 reference

8 September 2017

Hong Li

5

1 reference

8 September 2017

Desheng Wang

6

1 reference

8 September 2017

publication date

1 July 2014

1 reference

Microbiology and Immunology

8 September 2017

published in

1 reference

8 September 2017

volume

58

1 reference

8 September 2017

issue

7

1 reference

8 September 2017

page(s)

409-415

1 reference

The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

The role of regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

FOXP3 defines regulatory T cells in human tumor and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

An up-to-date anti-cancer treatment strategy focusing on HIF-1alpha suppression: its application for refractory ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

HIF-1 and HIF-2: working alone or together in hypoxia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

Preferential expression of the novel alternative isoform I.3 of hypoxia-inducible factor 1alpha in activated human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12168

21 January 2018

Identifiers

DOI

10.1111/1348-0421.12168

1 reference

8 September 2017

1 reference